Atlas Trials

A Trial of DDI Between SHR1459 and Efavirenz With Healthy Subjects

Clinical trial NCT05560360 · COMPLETED

Trial details

NCT number
NCT05560360
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
B-cell Tumors
Start date
2022-11-04
Primary completion
2022-12-02
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.